Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Sol Gel Technologies Ltd
SLGLCurrent price
0.62 USD
-0.025 USD (-3.88%)
Last closed
0.63 USD
Company
www.sol-gel.com
ISIN
IL0011417206
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
18 940 382 USD
Yield for 12 month
-72.69 %
1Y
3Y
5Y
10Y
15Y
SLGL
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel. Address: 7 Golda Meir Street, Ness Ziona, Israel, 7403650
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
+1 554 000 USD
Last Year
+3 883 000 USD
Current Quarter
+5 433 000 USD
Last Quarter
+466 000 USD
Current Year
+1 212 000 USD
Last Year
-8 799 000 USD
Current Quarter
+5 433 000 USD
Last Quarter
-4 879 000 USD
Key Figures SLGL
1 year
3 years
5 years
10 years
EBITDA
-16 520 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-21.63 %
PEG Ratio
–
Return On Equity TTM
-35.85 %
Wall Street Target Price
5 USD
Revenue TTM
6 559 000 USD
Book Value
1.25 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
814.6 %
Dividend Yield
–
Gross Profit TTM
-8 799 000 USD
Earnings per share
-0.54 USD
Diluted Eps TTM
-0.54 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-227.4 %
Dividend Analytics SLGL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SLGL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation SLGL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
9.3371
Enterprise Value Revenue
0.1304
Price Sales TTM
2.8877
Enterprise Value EBITDA
0.2353
Price Book MRQ
0.5427
Financials SLGL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SLGL
For 52 weeks
0.33 USD
2.61 USD
50 Day MA
0.64 USD
Shares Short Prior Month
438 714
200 Day MA
0.93 USD
Short Ratio
0.24
Shares Short
198 803
Short Percent
1.66 %
BeatStart